Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Garima
    Garima

      Garima joined Medical Dialogues in the year 2017 and is currently working as a Senior Editor. She looks after all the Healthcare news pertaining to Medico-legal cases, MCI/DCI decisions, Medical Education issues, government policies as well as all the news and updates concerning Medical and Dental Colleges in India. She is a graduate from Delhi University. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      • Home
      • Garima

      Articles By : Garima

      Diabetes Test Strips Fraud: Roche sues US executives for $84 million

      Diabetes Test Strips Fraud: Roche sues US executives for $84 million

      Garima22 March 2019 11:00 AM IST
      Roche has filed several lawsuits in U.S. federal court in which it alleges individuals and companies obtained low-priced diabetes test strips meant...
      Grewal Eye Institute lauds study by Duke Eye Center

      Grewal Eye Institute lauds study by Duke Eye Center

      Garima22 March 2019 9:00 AM IST
      Chandigarh: Alzheimer's is the most common type of dementia with no cure and treatment. It disrupts the daily life of a person. There are millions of...
      GSK reports positive data from trial of cancer drug Dostarlimab

      GSK reports positive data from trial of cancer drug Dostarlimab

      Garima21 March 2019 9:15 AM IST
      GSK said it would apply for marketing approval for Dostarlimab in endometrial cancer at the end of 2019.New Delhi: GlaxoSmithKline said on Tuesday a...
      Novartis division Alcon acquires Power Vision

      Novartis division Alcon acquires Power Vision

      Garima20 March 2019 9:47 AM IST
      Under the terms of the agreement, Alcon, a Novartis division paid USD 285 million to PowerVision at closing with additional payments based on...
      Merck, Enigma Biomedical signs license agreement for Novel MK 6884 Imaging Agent

      Merck, Enigma Biomedical signs license agreement for Novel MK 6884 Imaging Agent

      Garima20 March 2019 9:46 AM IST
      As part of the agreement with Merck, EBG will be responsible for the clinical development and commercialization of MK-6884 in return for payment of...
      Blackstone belatedly buys into Abenomics

      Blackstone belatedly buys into Abenomics

      Garima20 March 2019 9:45 AM IST
      After focusing mainly on real estate, Blackstone's maiden Japanese acquisition doesn't fit the common country playbook of a corporate carveout. More...
      Dr Reddys launches B2B Customer Service Portal XCEED

      Dr Reddys launches B2B Customer Service Portal XCEED

      Garima19 March 2019 10:00 AM IST
      Dr Reddys launch of XCEED gives now instant access to an industry-leading portfolio which spans across a wide range of indications and complex...
      Alembic Pharma raises Rs 150 crore via NCDs

      Alembic Pharma raises Rs 150 crore via NCDs

      Garima19 March 2019 9:45 AM IST
      "The NCD Committee of Alembic Pharma Ltd at its meeting held today has allotted 1,500, 8.37 per cent unsecured listed rated redeemable NCDs of Rs...
      Anixa Biosciences gets US patent for additional cancer detection technology

      Anixa Biosciences gets US patent for additional cancer detection technology

      Garima18 March 2019 9:20 AM IST
      This patent provides broader coverage for the use of Anixa's technology in a wider range of applications and protects critical new improvements...
      Suven Life Sciences provide financial assistance of Rs 70 lakh to Bharosa

      Suven Life Sciences provide financial assistance of Rs 70 lakh to Bharosa

      Garima17 March 2019 10:21 AM IST
      Suven Life Sciences has also agreed to provide contribute yearly maintenance cost of Rs 30 lakh over the next five years for the centre.Hyderabad: As...
      Malvinder Singh alleges spiritual guru invested Ranbaxy stake sale proceeds to buy real estate

      Malvinder Singh alleges spiritual guru invested Ranbaxy stake sale proceeds to buy real estate

      Garima16 March 2019 1:27 PM IST
      Malvinder Singh alleged that Dhillon invested the funds in commercial properties, including a prime 260,000 sq. ft land in Delhi (near the Select City...
      Sun Pharma raises stake in Russias PJSC Biosintez to 96.96 percent

      Sun Pharma raises stake in Russias PJSC Biosintez to 96.96 percent

      Garima16 March 2019 9:35 AM IST
      The company's wholly-owned subsidiary, Sun Pharma (Netherlands) BV, has increased its shareholding in PJSC Biosintez by way of purchase of 33,958...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok